drugset / Trial / NCT06547502
Pharmacokinetics and Safety Profile of a Single Dose GZR4 in Subjects with Renal Impairment
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study will be conducted to investigated the effect of decreased kidney function on PK and safety of GZR4 and to guide dosing recommendations in people with kidney impairment.
Timeline
- Start
- 2024-07-03
- Primary completion
- 2024-08-20
- Completion
- 2024-09-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GZR4 | Unknown | — | — |